Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Terminal Malignant Tumors”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT04495530
What this trial is testing

Information Needs Around Parenteral nUTrition in Cancer

Who this might be right for
CancerEnd Stage CancerTerminal Cancer+4 more
Royal Marsden NHS Foundation Trust 12
Large-scale testing (Phase 3)UnknownNCT00417053
What this trial is testing

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Not applicableStudy completedNCT03840720
What this trial is testing

The Patient's Journey - the Time to Final Diagnosis in Patients With SiNET

Who this might be right for
Neuroendocrine Tumors
Vastra Gotaland Region 20
Testing effectiveness (Phase 2)Study completedNCT00067288
What this trial is testing

Meaning-Centered Psychotherapy in Advanced Cancer

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
National Center for Complementary and Integrative Health (NCCIH) 118
Early research (Phase 1)Study completedNCT04587479
What this trial is testing

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors, Adult
Jacobio Pharmaceuticals Co., Ltd. 41
Testing effectiveness (Phase 2)WithdrawnNCT02986919
What this trial is testing

Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Peripheral Nerve Tumors
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT07164352
What this trial is testing

Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients

Who this might be right for
Palliative PatientsTerminal Malignant TumorsBreathing Techniques
Atlas University 58
Testing effectiveness (Phase 2)Study completedNCT05963386
What this trial is testing

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Who this might be right for
Refractory Solid Tumor
The First Affiliated Hospital of Xiamen University 28
Early research (Phase 1)Study completedNCT03936465
What this trial is testing

Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer

Who this might be right for
Solid Tumor, ChildhoodLymphomaBrain Tumor, Pediatric
Dana-Farber Cancer Institute 41
Not applicableWithdrawnNCT03577600
What this trial is testing

Compassionate Treatment in Children With Brain Tumors With the Cytotron®

Who this might be right for
Pediatric Brain Tumor
Hospital Infantil de Mexico Federico Gomez
Not applicableStudy completedNCT05118802
What this trial is testing

Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 46
Not applicableStudy completedNCT01358617
What this trial is testing

Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+2 more
Children's Oncology Group 90
Early research (Phase 1)Study completedNCT01865162
What this trial is testing

Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study

Who this might be right for
Glioblastoma Multiforme
Mid-Atlantic Epilepsy and Sleep Center, LLC 6
Testing effectiveness (Phase 2)Looking for participantsNCT04686682
What this trial is testing

A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

Who this might be right for
NSCLCSCLCCRPC+5 more
Jacobio Pharmaceuticals Co., Ltd. 152
Not applicableStudy completedNCT03746392
What this trial is testing

Project to Improve Communication About Serious Illness - Pilot Study

Who this might be right for
Malignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more
University of Washington 150
Not applicableNot Yet RecruitingNCT06962553
What this trial is testing

Nurses' Competence and Role in Survival Prediction and Prognostic Communication

Who this might be right for
Advanced CancerTerminal Malignant TumorsHospices
National Taiwan University Hospital 152
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Testing effectiveness (Phase 2)Ended earlyNCT02296476
What this trial is testing

A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)

Who this might be right for
Glioblastoma Multiforme
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 12
Early research (Phase 1)UnknownNCT04805060
What this trial is testing

Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors

Who this might be right for
Terminal Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Load More Results